Clostridium difficile infections elevate the risks for colectomy, mortality and postoperative complications after a colectomy for patients with ulcerative colitis, according to NEJM Journal Watch.
A novel vaccination approach developed by Vanderbilt Health researchers cleared the harmful gut bacterium Clostridioides difficile (C. diff) in an animal model of infection. An experimental vaccine ...
REBYOTA is indicated for the prevention of recurrence of Clostridioides difficile (C. diff) infection in individuals 18 years of age and older, following antibiotic treatment for recurrent C. diff ...
An inflammation of the colon associated with C. difficile — C. difficile colitis — has increased nearly 50 percent from 2001-2005 to 2006-2010, according to a study in the Journal of the American ...
Why Do People Get a Colonoscopy for Ulcerative Colitis? Ulcerative colitis is a type of inflammatory bowel disease that causes inflammation and sores to form in the large intestine and rectum. It ...
In a phase-one human clinical trial, a University of Houston pharmacist researcher has demonstrated that a newer generation tetracycline antibiotic, called Omadacycline, may be a promising tool in ...
Please provide your email address to receive an email when new articles are posted on . More than 50% of adenomas developed within 7.5 months of immune checkpoint inhibitor-mediated diarrhea and ...
People with ulcerative colitis (UC), a chronic inflammatory bowel disease, are up to four times more likely to develop colorectal cancer than the general population. Low-grade dysplasia (LGD)—abnormal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results